Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calles-Escandon, J.
Right arrow Articles by Robbins, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calles-Escandon, J.
Right arrow Articles by Robbins, D. C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 36, Issue 10 1167-1172, Copyright © 1987 by American Diabetes Association


ARTICLES

Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose

J Calles-Escandon and DC Robbins
Department of Medicine, University of Vermont, Burlington 05401.

Loss of the early phase of insulin release has been documented in both type I (insulin-dependent) and type II (non-insulin-dependent) diabetes; however, the physiological importance of this loss is unsettled. We created a model of loss of the early phase of insulin release in normal volunteers. Somatostatin (SRIF) was briefly infused (from -5 to 15 min) during intravenous (IVGTT) and oral (OGTT) glucose tolerance tests. The thermic response to oral glucose was determined under these conditions by indirect calorimetry. Early insulin release was totally blocked during IVGTT and OGTT by SRIF infusion. During the IVGTT, glucose tolerance was deteriorated in association with loss of the early phase of insulin release as indicated by a decrease in the K value (control 1.9 +/- 0.36 vs. SRIF 1.1 +/- 0.27, P less than .001). Higher plasma glucose concentrations were observed during SRIF tests in the OGTT at 60, 90, 120, 150, and 180 min; total glycemic excursion was larger during the SRIF test (9473 +/- 3089 mg X dl-1 X 5 h-1) when compared with the control condition (6583 +/- 2329 mg X dl-1 X 5 h-1). During the OGTT the total amount of glucose oxidized (control 56 +/- 4.2 vs. SRIF 55 +/- 3.4 g/5 h) was similar in both conditions, suggesting that nonoxidative pathways of glucose disposal were responsible for the deterioration in glucose tolerance. Surprisingly, we found that glucose-induced thermogenesis was reduced in association with loss of the early phase of insulin release (control 102 +/- 21.3 vs. SRIF 72 +/- 27.8 J/5 h, P less than .001).(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Doi, M. Kubo, K. Yonemoto, T. Ninomiya, M. Iwase, H. Arima, J. Hata, Y. Tanizaki, M. Iida, and Y. Kiyohara
Fasting Plasma Glucose Cutoff for Diagnosis of Diabetes in a Japanese Population
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3425 - 3429.
[Abstract] [Full Text] [PDF]


Home page
JAOA: Journal of the American Osteopathic AssociationHome page
C. W. Spellman
Islet Cell Dysfunction in Progression to Diabetes Mellitus
J Am Osteopath Assoc, May 1, 2007; 107(suppl_3): S1 - S5.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Teff
Learning Hunger: Conditioned Anticipatory Ghrelin Responses in Energy Homeostasis
Endocrinology, January 1, 2006; 147(1): 20 - 22.
[Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
S. Del Prato, R. Miccoli, and G. Penno
Review: The importance of effective early phase insulin secretion
The British Journal of Diabetes & Vascular Disease, July 1, 2005; 5(4): 198 - 202.
[Abstract] [PDF]


Home page
Diabetes CareHome page
L. S. Cozma, S. D. Luzio, G. J. Dunseath, P. M. Underwood, and D. R. Owens
{beta}-Cell Response During a Meal Test: A comparative study of incremental doses of repaglinide in type 2 diabetic patients
Diabetes Care, May 1, 2005; 28(5): 1001 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Caumo and L. Luzi
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E371 - E385.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. E. Gerich
Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
Arch Intern Med, June 9, 2003; 163(11): 1306 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Ahren and G. Pacini
Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice
Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E738 - E744.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. S. Cozma, S. D. Luzio, G. J. Dunseath, K. W. Langendorg, T. Pieber, and D. R. Owens
Comparison of the Effects of Three Insulinotropic Drugs on Plasma Insulin Levels After a Standard Meal
Diabetes Care, August 1, 2002; 25(8): 1271 - 1276.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M D. Robertson, A. O Mason, and K. N Frayn
Timing of vagal stimulation affects postprandial lipid metabolism in humans
Am. J. Clinical Nutrition, July 1, 2002; 76(1): 71 - 77.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Del Prato, P. Marchetti, and R. C. Bonadonna
Phasic Insulin Release and Metabolic Regulation in Type 2 Diabetes
Diabetes, February 1, 2002; 51(90001): S109 - 116.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. E. Gerich
Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes?
Diabetes, February 1, 2002; 51(90001): S117 - 121.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. A. Hollander, S. L. Schwartz, M. R. Gatlin, S. J. Haas, H. Zheng, J. E. Foley, and B. E. Dunning
Importance of Early Insulin Secretion: Comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes
Diabetes Care, June 1, 2001; 24(6): 983 - 988.
[Abstract] [Full Text]


Home page
DiabetesHome page
B. Ahrén and J. J. Holst
The Cephalic Insulin Response to Meal Ingestion in Humans Is Dependent on Both Cholinergic and Noncholinergic Mechanisms and Is Important for Postprandial Glycemia
Diabetes, May 1, 2001; 50(5): 1030 - 1038.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
M D. Robertson, K. G Jackson, C. M Williams, B. A Fielding, and K. N Frayn
Prolonged effects of modified sham feeding on energy substrate mobilization
Am. J. Clinical Nutrition, January 1, 2001; 73(1): 111 - 117.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Weyer, P. A. Tataranni, C. Bogardus, and R. E. Pratley
Insulin Resistance and Insulin Secretory Dysfunction Are Independent Predictors of Worsening of Glucose Tolerance During Each Stage of Type 2 Diabetes Development
Diabetes Care, January 1, 2001; 24(1): 89 - 94.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. L. Teff and R. R. Townsend
Early phase insulin infusion and muscarinic blockade in obese and lean subjects
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R198 - R208.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. E. Gerich
The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity
Endocr. Rev., August 1, 1998; 19(4): 491 - 503.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1987 by the American Diabetes Association.